These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 2563653

  • 1. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G, Kula NS, Baldessarini RJ.
    Biochem Pharmacol; 1989 Feb 01; 38(3):473-80. PubMed ID: 2563653
    [Abstract] [Full Text] [Related]

  • 2. [3H]SCH 23390 identifies D-1 binding sites in rat striatum and other brain areas.
    Kilpatrick GJ, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1986 Dec 01; 38(12):907-12. PubMed ID: 2880965
    [Abstract] [Full Text] [Related]

  • 3. Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.
    Flaim KE, Gessner GW, Crooke ST, Heys JR, Weinstock J.
    Life Sci; 1986 Jun 09; 38(23):2087-96. PubMed ID: 2872567
    [Abstract] [Full Text] [Related]

  • 4. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ, Battaglia G, Norman AB, Iorio LC, Creese I.
    Eur J Pharmacol; 1986 Feb 11; 121(1):31-8. PubMed ID: 2869957
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.
    Billard W, Ruperto V, Crosby G, Iorio LC, Barnett A.
    Life Sci; 1984 Oct 29; 35(18):1885-93. PubMed ID: 6387355
    [Abstract] [Full Text] [Related]

  • 6. Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions.
    Hyttel J, Arnt J.
    J Neural Transm; 1987 Oct 29; 68(3-4):171-89. PubMed ID: 2881976
    [Abstract] [Full Text] [Related]

  • 7. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH, Dvorkin B.
    Brain Res; 1986 Dec 29; 387(3):261-70. PubMed ID: 2950967
    [Abstract] [Full Text] [Related]

  • 8. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
    Srivastava LK, Ross GM, Bajwa SB, Mishra RK.
    Neurochem Res; 1990 Jun 29; 15(6):647-57. PubMed ID: 1977093
    [Abstract] [Full Text] [Related]

  • 9. Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum.
    Flaim KE, Gessner GW, Crooke ST, Sarau HM, Weinstock J.
    Life Sci; 1985 Apr 15; 36(15):1427-36. PubMed ID: 2858801
    [Abstract] [Full Text] [Related]

  • 10. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Mar 02; 98(3-4):433-6. PubMed ID: 6144559
    [Abstract] [Full Text] [Related]

  • 11. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
    Gredal O, Parkinson D, Nielsen M.
    Eur J Pharmacol; 1987 Jun 04; 137(2-3):241-5. PubMed ID: 2886353
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H, Högberg T, Halldin C, Bengtsson S, Wedel I.
    Eur J Pharmacol; 1991 Aug 16; 201(1):1-10. PubMed ID: 1686586
    [Abstract] [Full Text] [Related]

  • 13. Effects of heavy metal cations and other sulfhydryl reagents on brain dopamine D1 receptors: evidence for involvement of a thiol group in the conformation of the active site.
    Braestrup C, Andersen PH.
    J Neurochem; 1987 Jun 16; 48(6):1667-72. PubMed ID: 2952762
    [Abstract] [Full Text] [Related]

  • 14. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA, Bennett JP.
    Brain Res; 1987 Jul 07; 415(1):90-7. PubMed ID: 2957025
    [Abstract] [Full Text] [Related]

  • 15. Effects of sodium, lithium, and magnesium on in vitro binding of [3H]SCH23390 in rat neostriatum and cerebral cortex.
    Gottberg E, Diop L, Montreuil B, Reader TA.
    Neurochem Res; 1989 May 07; 14(5):419-26. PubMed ID: 2526301
    [Abstract] [Full Text] [Related]

  • 16. Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor.
    Schulz DW, Stanford EJ, Wyrick SW, Mailman RB.
    J Neurochem; 1985 Nov 07; 45(5):1601-11. PubMed ID: 2864398
    [Abstract] [Full Text] [Related]

  • 17. Picomolar affinity of 125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography.
    Altar CA, Marien MR.
    J Neurosci; 1987 Jan 07; 7(1):213-22. PubMed ID: 2949066
    [Abstract] [Full Text] [Related]

  • 18. [3H]Fluphenazine binding to brain membranes: simultaneous measurement of D-1 and D-2 receptor sites.
    Morgan DG, Finch CE.
    J Neurochem; 1986 May 07; 46(5):1623-31. PubMed ID: 2937884
    [Abstract] [Full Text] [Related]

  • 19. Serotonergic component of SCH 23390: in vitro and in vivo binding analyses.
    McQuade RD, Ford D, Duffy RA, Chipkin RE, Iorio LC, Barnett A.
    Life Sci; 1988 May 07; 43(23):1861-9. PubMed ID: 2904635
    [Abstract] [Full Text] [Related]

  • 20. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor.
    Niznik HB, Otsuka NY, Dumbrille-Ross A, Grigoriadis D, Tirpak A, Seeman P.
    J Biol Chem; 1986 Jun 25; 261(18):8397-406. PubMed ID: 3522568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.